#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Scleroderma associated digital ulcer Cervix carcinoma Tuberous sclerosis complex Cardiac sarcoidosis Central nervous system lymphoma Pancreatic carcinoma Retinopathy proliferative Glycogen storage disease type II Rett syndrome Soft tissue necrosis Non-small cell lung cancer metastatic Leukoencephalopathy Retinitis pigmentosa Acute myeloid leukaemia recurrent Kearns-Sayre syndrome More trials…

    Learn about Rare Diseases

    Chondrosarcoma metastatic – Treatment Angiosarcoma recurrent – Diagnostics Langerhans cell sarcoma – Life with Disease Pleural mesothelioma malignant – Trials in Disease Undifferentiated sarcoma – Life with Disease Alternating hemiplegia of childhood Mantle cell lymphoma stage IV – Trials in Disease Pleural mesothelioma malignant Glycogen storage disease type I – Trials in Disease Pulmonary sarcoidosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Olopatadine Regadenoson Natalizumab Reboxetine Roginolisib Bay 3283142 Ly3871801 Bi 1015550 IHMA-2121771-2 Ceftolozane Fluorodopa (18F) Ropeginterferon Alfa-2B Prasugrel Hydrobromide Efpegerglucagon Estradiol Valerate Nortriptyline Hydrochloride ALG-000184 Chlorpromazine VTX-002 ALENDRONATE SODIUM TRIHYDRATE More therapies…

    Learn about Your Condition

    Neuropathy peripheral Shprintzen-Goldberg syndrome Lip and/or oral cavity cancer Angiosarcoma metastatic Seasonal allergy Nicotine dependence Renal transplant Raynaud's phenomenon Relapsing multiple sclerosis Metastases to lymph nodes Lichen planopilaris Pleomorphic leiomyosarcoma Hypotonia Gastric cancer recurrent Hyperplasia adrenal More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Polypoidal choroidal vasculopathy

  • Study on the Effects of Faricimab for Caucasian Patients with Polypoidal Choroidal Vasculopathy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Polypoidal choroidal vasculopathy
    Investigated Drugs:
    • Faricimab
    Italy Portugal Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!